We are live on ! Find out more
DBG

De Burlo Group Portfolio holdings

AUM $441M
1-Year Est. Return 21.21%
This Fund
S&P 500
This Quarter Est. Return
-4.81%
1 Year Est. Return
+21.21%
3 Year Est. Return
+98.05%
5 Year Est. Return
+220.33%
10 Year Est. Return
+1,846.98%
AUM
$426M
AUM Growth
-$51.7M
Cap. Flow
-$20.6M
Cap. Flow %
-4.84%
Top 10 Hldgs %
29.07%
Holding
112
New
8
Increased
28
Reduced
43
Closed
13

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$11.4M
2
CCI icon
Crown Castle
CCI
+$5.45M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$5.4M
4
FTNT icon
Fortinet
FTNT
+$5.12M
5
SBUX icon
Starbucks
SBUX
+$4.84M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$9.01M
2
AAPL icon
Apple
AAPL
+$8.76M
3
SIAL
SIGMA - ALDRICH CORP
SIAL
+$6.44M
4
QRVO icon
Qorvo
QRVO
+$5.01M
5
NXPI icon
NXP Semiconductors
NXPI
+$4.8M

Sector Composition

Rank Sector Weight
1 Healthcare 34.36%
2 Consumer Discretionary 18.93%
3 Technology 18.76%
4 Industrials 8.65%
5 Financials 8.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XRAY icon
51
Dentsply Sirona
XRAY
$2.55B
$3.07M 0.72%
+60,800
New +$3.24M
ESRX
52
DELISTED
Express Scripts Holding Company
ESRX
$2.83M 0.66%
34,992
+528
+2% +$46K
BFX
53
DELISTED
BowFlex Inc.
BFX
$2.69M 0.63%
179,300
-111,900
-38% -$2.01M
BMY icon
54
Bristol-Myers Squibb
BMY
$126B
$2.63M 0.62%
44,387
+9,000
+25% +$571K
VZ icon
55
Verizon
VZ
$183B
$2.49M 0.58%
57,140
+90
+0.2% +$4.15K
PNC icon
56
PNC Financial Services
PNC
$99.5B
$2.36M 0.55%
26,500
-8,700
-25% -$818K
GIS icon
57
General Mills
GIS
$19B
$2.21M 0.52%
39,300
-8,094
-17% -$464K
NBIX icon
58
Neurocrine Biosciences
NBIX
$17.5B
$2.12M 0.5%
53,350
-4,000
-7% -$193K
DOC icon
59
Healthpeak Properties
DOC
$15.2B
$1.97M 0.46%
58,029
-2,087
-3% -$72.2K
OKE icon
60
Oneok
OKE
$58.7B
$1.91M 0.45%
59,350
-3,400
-5% -$124K
MDSO
61
DELISTED
Medidata Solutions, Inc.
MDSO
$1.83M 0.43%
43,600
-7,900
-15% -$401K
PG icon
62
Procter & Gamble
PG
$342B
$1.77M 0.41%
24,575
+300
+1% +$22.5K
SMED
63
DELISTED
Sharps Compliance Corp
SMED
$1.75M 0.41%
+199,743
New +$1.44M
ATO icon
64
Atmos Energy
ATO
$29.7B
$1.43M 0.33%
24,500
DFS
65
DELISTED
Discover Financial Services
DFS
$1.33M 0.31%
25,600
-35,300
-58% -$1.94M
T icon
66
AT&T
T
$160B
$1.2M 0.28%
48,600
+2,651
+6% +$67.6K
AMBA icon
67
Ambarella
AMBA
$3.09B
$1.18M 0.28%
20,400
-33,700
-62% -$3.18M
BCE icon
68
BCE
BCE
$19.8B
$1.02M 0.24%
25,000
-600
-2% -$24.6K
MAS icon
69
Masco
MAS
$15.6B
$898K 0.21%
35,700
-1,513
-4% -$38.8K
GMCR
70
DELISTED
KEURIG GREEN MTN INC
GMCR
$891K 0.21%
17,100
-250
-1% -$15.4K
MMM icon
71
3M
MMM
$87.5B
$851K 0.2%
7,176
-27,388
-79% -$3.37M
SFL icon
72
SFL Corp
SFL
$1.58B
$693K 0.16%
42,655
CTSH icon
73
Cognizant
CTSH
$20.3B
$651K 0.15%
10,400
+1,000
+11% +$62.8K
KYN icon
74
Kayne Anderson Energy Infrastructure Fund
KYN
$2.53B
$545K 0.13%
23,541
-1,406
-6% -$38.8K
NW.PRC.CL
75
DELISTED
Natwest Bank Ads Series C
NW.PRC.CL
$538K 0.13%
21,100

Similar funds

De Burlo Group's Q3 2015 Portfolio in Review

As of Q3 2015, De Burlo Group held 112 positions worth $426M, down 11% from $478M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

De Burlo Group withdrew a net $20.6M in Q3 2015, closing 13 positions and reducing 43 holdings. Its most notable exit was Biogen, an estimated $9.01M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 33% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, De Burlo Group opened a new position in Allergan plc worth $10.1M.

  • De Burlo Group's largest Q3 2015 buy was Allergan plc: 37,185 shares worth $10.1M.
  • De Burlo Group added most to Starbucks in Q3 2015, an estimated $4.84M increase.
  • De Burlo Group's biggest Q3 2015 reduction was Apple, cutting an estimated $8.76M.
  • De Burlo Group fully exited Biogen in Q3 2015, selling an estimated $9.01M.
  • De Burlo Group's ten largest holdings make up 29% of its $426M portfolio in Q3 2015.
  • De Burlo Group opened 8 new positions and closed 13 in Q3 2015.
  • De Burlo Group's portfolio value fell 11% quarter-over-quarter to $426M.

Based on De Burlo Group's 13F filing for Q3 2015, filed 5 Nov 2015.